Exercise During Chemotherapy for Patients With Hematological Malignancies

Phase 3

• Conditions: Hematological Malignancies; Hematological Diseases

• Registration Number: NCT00884364
• Lead Sponsor: Charite University, Berlin, Germany

Brief Summary

The trial will evaluate the effects of aerobic exercise in patients undergoing chemotherapy for the treatment of a hematological neoplastic disease.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2009-04-17
• Study First Submitted QC: 2009-04-17
• Study First Posted: 2009-04-20
• Study Start: 2009-05
• Status Verified: 2009-12
• Last Update Submitted: 2009-12-21
• Last Update Posted: 2009-12-23
• Primary Completion: 2011-04
• Study Completion: 2011-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Hematological malignant disease
• Current chemotherapy
• Understanding of written German

Exclusion Criteria

• Cardiorespiratory, metabolical, osteoarticular or immunological disorders which can be aggravated by exercise
• Pathological stress-ECG at recruitment

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Fatigue	At recruitment and after 12 weeks

Secondary Outcome Measures

Name	Time	Method
Physical performance	At recruitment and after 12 weeks
Complications	At recruitment and after 12 weeks

Trial Locations

Locations (1)

Section Sports Medicine, Charité Universitätsmedizin Berlin, Hindenburgdamm 30; 🇩🇪 Berlin, Germany